Page last updated: 2024-11-07

sdz 880-431

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

SDZ 880-431: structure given in first source; inhibits the action of lipopolysaccharides on neutrophils [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127963
MeSH IDM0215908

Synonyms (8)

Synonym
sdz 880.431
101662-30-0
alpha-d-glucopyranose, 2,3-dideoxy-2,3-bis((3-hydroxy-1-oxotetradecyl)amino)-1,4-bis(dihydrosuphosphate), (2(r),3(r))-
sdz-880-431
sdz 880-431
sdz-880.431
2,3-dideoxy-2,3-bis{[(1,3-dihydroxytetradecylidene)amino]}-1,4-di-o-phosphonohexopyranose
DTXSID10906463
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]